The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this approach offers a more convenient way to provide https://kobihhae691975.blog-eye.com/41317531/glp-1-patches-a-new-approach-to-blood-sugar-control